{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiasn5erjlunian23riilimmztwvc7qpugqfymyzxydppnvpc6vxpm",
    "uri": "at://did:plc:z4547lu5ykj2ot3no6fwz5n4/app.bsky.feed.post/3mgpo5izs2lk2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreibaybieixmkyxel5nuapi7abvuy25xglnxs5wzc7fcqn2xjl2ry3u"
    },
    "mimeType": "image/jpeg",
    "size": 29916
  },
  "path": "/article/news/nation-world/fda-approves-drug-generic-medication-rare-brain-disorder-not-autism/507-b07f71c0-a821-4049-a4a2-1efab2728dbf",
  "publishedAt": "2026-03-10T14:16:44.000Z",
  "site": "https://www.wnep.com",
  "tags": [
    "nation-world",
    "news",
    "cct-tracking",
    "syndication",
    "health",
    "national-politics",
    "politics",
    "associatedpress"
  ],
  "textContent": "The FDA is approving a generic drug for a very rare genetic disorder that impacts fewer than 1 in a million people in the U.S.",
  "title": "FDA finds little evidence that a generic drug could help many people with autism"
}